
Keywords: ارزیابی ریسک و کاهش استراتژی; animal rule; compassionate use; emergency use authorization; intermediate IND; widespread-treatment IND; CMV; cytomegalovirus; EA; expanded access; EUA; emergency use authorization; FDA; U.S. Food and Drug Administration; IND; investigational new drug; RE